ZURCHER KANTONALBANK (ZURICH CANTONALBANK) – Regeneron Pharmaceuticals, Inc. Transaction History
ZURCHER KANTONALBANK (ZURICH CANTONALBANK) portfolio value:
$23.41M
portfolio value
ZURCHER KANTONALBANK (ZURICH CANTONALBANK) quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.63% | 544 shares | 3.64M | $688.87 | 33.99K |
| Q2 2022 | share | Decrease | -19.23% | -7.96K shares | -9.15M | $591.13 | 33.44K |
| Q1 2022 | share | Increase | +20.56% | 7.06K shares | 7.23M | $698.42 | 41.41K |
| Q4 2021 | share | Decrease | -31.78% | -16.00K shares | -8.78M | $642.51 | 34.35K |
| Q3 2021 | share | Decrease | -16.89% | -10.23K shares | -3.36M | $605.18 | 50.35K |
| Q2 2021 | share | Increase | +15.51% | 8.13K shares | 9.02M | $558.54 | 60.58K |
| Q1 2021 | share | Increase | +13.28% | 6.15K shares | 2.44M | $473.14 | 52.45K |
| Q4 2020 | share | Increase | +22.98% | 8.65K shares | 1.29M | $483.11 | 46.30K |
| Q3 2020 | share | Increase | +14.70% | 4.82K shares | 604K | $559.78 | 37.65K |
| Q2 2020 | share | Decrease | -13.88% | -5.29K shares | 1.85M | $623.65 | 32.82K |
| Q1 2020 | share | Increase | +89.39% | 17.99K shares | 11.05M | $488.29 | 38.12K |
| Q4 2019 | share | Increase | +2.95% | 577 shares | 2.13M | $375.48 | 20.12K |
| Q3 2019 | share | Increase | +1.32% | 254 shares | -617K | $277.4 | 19.55K |
| Q2 2019 | share | Decrease | -8.35% | -1.75K shares | -2.60M | $313 | 19.29K |
| Q1 2019 | share | Increase | +14.70% | 2.69K shares | 1.79M | $410.62 | 21.05K |
| Q4 2018 | share | Increase | +22.31% | 3.34K shares | 792K | $373.5 | 18.35K |
| Q3 2018 | share | Decrease | -2.97% | -459 shares | 728K | $404.04 | 15.00K |
| Q2 2018 | share | Increase | +4.25% | 630 shares | 227K | $344.99 | 15.46K |
| Q1 2018 | share | 0.00% | 0 shares | -469K | $344.36 | 14.83K | |
| Q4 2017 | share | Decrease | -17.36% | -3.11K shares | -2.45M | $375.96 | 14.83K |
| Q3 2017 | share | Increase | +9.76% | 1.59K shares | -6K | $447.12 | 17.95K |
| Q2 2017 | share | Decrease | -7.35% | -1.29K shares | 1.19M | $491.14 | 16.35K |
| Q1 2017 | share | Decrease | -8.62% | -1.66K shares | -251K | $387.51 | 17.65K |
| Q4 2016 | share | Increase | +17.10% | 2.82K shares | 459K | $367.09 | 19.32K |
| Q3 2016 | share | Increase | +116.98% | 8.89K shares | 3.97M | $402.02 | 16.50K |
| Q2 2016 | share | Increase | +7.04% | 500 shares | 95K | $349.23 | 7.60K |
| Q1 2016 | share | Increase | +3.51% | 241 shares | -1.16M | $360.44 | 7.10K |